LEP and metabolic dysfunction-associated steatotic liver disease: Leptin is an adipokine that has different effects on MASLD progression: in the early stages of the disease, it has a protective role against steatosis by preventing hepatic lipid accumulation, but as the disease progresses, leptin could have a proinflammatory and profibrogenic role [52,53].